Daré Bioscience, Inc. (DARE)
0.8428
-0.01
(-0.96%)
USD |
NASDAQ |
Oct 02, 16:00
0.8353
-0.01
(-0.89%)
After-Hours: 20:00
Daré Bioscience Net Income (Quarterly) : -2.983M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.983M |
| March 31, 2026 | -3.000M |
| December 31, 2025 | -1.442M |
| September 30, 2025 | -3.563M |
| June 30, 2025 | -4.016M |
| March 31, 2025 | -4.378M |
| September 30, 2024 | -4.702M |
| June 30, 2024 | 12.91M |
| March 31, 2024 | -6.755M |
| December 31, 2023 | -5.058M |
| September 30, 2023 | -8.299M |
| June 30, 2023 | -8.762M |
| March 31, 2023 | -8.042M |
| December 31, 2022 | -15.94M |
| September 30, 2022 | -7.020M |
| June 30, 2022 | 0.414M |
| March 31, 2022 | -8.399M |
| December 31, 2021 | -9.542M |
| September 30, 2021 | -12.67M |
| June 30, 2021 | -9.163M |
| March 31, 2021 | -7.324M |
| December 31, 2020 | -8.442M |
| September 30, 2020 | -7.583M |
| June 30, 2020 | -7.124M |
| March 31, 2020 | -4.252M |
| Date | Value |
|---|---|
| December 31, 2019 | -3.866M |
| September 30, 2019 | -3.393M |
| June 30, 2019 | -3.952M |
| March 31, 2019 | -3.052M |
| December 31, 2018 | -2.917M |
| September 30, 2018 | -2.574M |
| June 30, 2018 | -3.582M |
| March 31, 2018 | -7.666M |
| December 31, 2017 | -9.131M |
| September 30, 2017 | -1.630M |
| June 30, 2017 | -0.4982M |
| March 31, 2017 | -0.2439M |
| December 31, 2016 | -4.945M |
| September 30, 2016 | -9.959M |
| June 30, 2016 | -10.86M |
| March 31, 2016 | -13.54M |
| December 31, 2015 | -10.72M |
| September 30, 2015 | -10.55M |
| June 30, 2015 | -9.907M |
| March 31, 2015 | -8.428M |
| December 31, 2014 | -7.467M |
| September 30, 2014 | -5.558M |
| June 30, 2014 | -7.403M |
| March 31, 2014 | -2.914M |
| December 31, 2013 | -3.324M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Elite Pharmaceuticals, Inc. | 5.911M |
| Eton Pharmaceuticals, Inc. | 11.58M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.1875M |
| Total Expenses (Quarterly) | 3.170M |
| EPS Diluted (Quarterly) | -0.2003 |
| Enterprise Value | 6.932M |
| Gross Profit Margin (Quarterly) | -294.5% |
| Profit Margin (Quarterly) | -1.59K% |
| Earnings Yield | -93.21% |
| Normalized Earnings Yield | -93.21 |